Trintellix is classified as a medication for treating major depressive disorder (MDD) [1]. It works by modulating serotonin neurotransmission in the brain [2].
How does Trintellix work?
Trintellix (vortioxetine) is described as a multimodal antidepressant [1]. Its mechanism of action involves inhibiting the serotonin transporter (SERT), which increases serotonin levels in the synaptic cleft [2]. Additionally, vortioxetine acts as a serotonin receptor agonist and antagonist, affecting various serotonin receptors, including 5-HT1A, 5-HT1B, 5-HT3, 5-HT1D, and 5-HT7 receptors [2]. This multifaceted action is thought to contribute to its antidepressant effects and potential benefits for cognitive symptoms associated with depression [2].
What conditions is Trintellix approved to treat?
Trintellix is FDA-approved for the treatment of major depressive disorder (MDD) in adults [1].
When does Trintellix patent expire?
According to DrugPatentWatch.com, the primary patent for Trintellix (vortioxetine) is expected to expire in 2027 [3]. However, there may be other patents covering different aspects of the drug or its uses, which could extend market exclusivity [3].
Are there generic versions of Trintellix available?
As of now, generic versions of Trintellix are not widely available because the drug is still under patent protection [3]. Once patents expire, generic manufacturers can seek approval to produce and market their own versions of vortioxetine.
How does Trintellix compare to other antidepressants?
Trintellix is distinct from many other antidepressants due to its multimodal mechanism of action [2]. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) primarily target serotonin and norepinephrine transporters, respectively [4]. Trintellix, in addition to SERT inhibition, engages with multiple serotonin receptors, which may differentiate its efficacy and side effect profile [2]. Some studies have investigated its potential to improve cognitive function in patients with depression, an area where other antidepressants may have less direct impact [2].
What are the potential side effects of Trintellix?
Common side effects associated with Trintellix include nausea, vomiting, constipation, diarrhea, dizziness, abnormal dreams, and sexual dysfunction [1]. Serious side effects can occur, such as increased risk of bleeding, serotonin syndrome, activation of mania or hypomania, and angle-closure glaucoma [1].
What is the typical dosage for Trintellix?
The recommended starting dose for Trintellix is 10 mg once daily, which can be increased to 20 mg once daily or decreased to 5 mg once daily, depending on individual response and tolerability [1].
Who manufactures Trintellix?
Trintellix is manufactured by Takeda Pharmaceuticals [5].
Sources:
[1] https://www.trintellix.com/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461031/
[3] https://drugpatentwatch.com/
[4] https://www.nhs.uk/mental-health/talking-therapies-medicine-treatments/medicines-and-psychiatry/antidepressants/
[5] https://www.takeda.com/